PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

NCT03317821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-07-29

No results posted yet for this study

Summary

The primary objective of this study is to demonstrate the safety and efficacy of the PHIL® liquid in endovascular treatment of dural arteriovenous fistula.

Conditions

  • Dural Arteriovenous Fistula

Sponsors & Collaborators

  • ClinSearch

    collaborator OTHER
  • Microvention-Terumo, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-18
Primary Completion
2020-03-11
Completion
2020-03-11

Countries

  • Denmark
  • France
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317821 on ClinicalTrials.gov